• Alamar Biosciences appointed former GRAIL CEO Bob Ragusa to its board of directors.
• Ragusa brings more than two decades in genomics, diagnostics, and biotech; previously served as Illumina’s chief operations officer.
• John Brottem joined as general counsel; previously served as general counsel of Outset Medical, with senior legal roles at Omnicell.
• Amelia Merrill joined as chief people officer; previously led people functions at Guardant Health, RMS, Outset Medical, VeriSign, webMethods, Juniper Networks.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alamar Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610051605PRIMZONEFULLFEED9839811) on October 05, 2026, and is solely responsible for the information contained therein.